Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2010
12/21/2010CA2564872C Iap bir domain binding compounds
12/21/2010CA2464130C Mch antagonists for the treatment of obesity
12/21/2010CA2460956C Tetrapeptide derivative crystals
12/21/2010CA2448896C Allylmercaptocaptopril compounds and uses thereof
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/16/2010WO2010144386A2 Antimicrobial polymers
12/16/2010WO2010144371A1 Alkanoylamino benzamide aniline hdac inihibitor compounds
12/16/2010WO2010142650A1 Novel cyclopentane derivatives
12/16/2010US20100317870 Antimicrobial polymers
12/16/2010US20100317701 Heterocyclic inhibitors of necroptosis
12/16/2010US20100317690 Treatment of protein folding disorders
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317024 Derivatives, reagents, and immunoassay for detecting levetiracetam
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2763786A1 Alkanoylamino benzamide aniline hdac inihibitor compounds
12/16/2010CA2763167A1 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/16/2010CA2762619A1 Novel cyclopentane derivatives
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261205A1 Method of producing (s)-3-(1-cyano-1,1-diphenylmethyl)-pyrrolidine
12/15/2010EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/15/2010EP2260020A1 Hydroxamate-based inhibitors of deacetylases b
12/15/2010EP1634883B1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d] pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
12/15/2010CN1964943B Process for the preparation of n-akyl-pyrrolidones
12/15/2010CN1708480B Carotenoid analogs for the inhibition and amelioration of disease
12/15/2010CN101918411A Process for the preparation of asenapine and intermediate products used in said process
12/15/2010CN101918359A Sulfonamides as orexin antagonists
12/15/2010CN101918352A Inhibitors of 17beta-hydroxysteroid dehydrogenase
12/15/2010CN101914099A Covalently linked oligonucleotide minor groove binder conjugates
12/15/2010CN101914052A Oxiracetam compound and new method thereof
12/15/2010CN101914051A Synthesis method of 3-phenyl pyrroline derivatives with optical isomerism purity
12/15/2010CN101914040A Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
12/15/2010CN101912779A Catalyst for catalytic synthesis of N-methylpyrrolidine and application thereof
12/15/2010CN101141959B 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
12/15/2010CN101023091B Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports
12/15/2010CN101012211B Substituted andrographolide derivative, preparing method and pharmaceutical compound thereof
12/14/2010US7851642 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compound
12/14/2010US7851505 for the treatment of diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or nuclear factor kappa beta dysregulation
12/14/2010US7851463 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
12/14/2010US7850955 contain a specific N-acylamino acid monoamide monoalkyl ester; do not cause sweating while retaining a practical level of gel strength; good spreadability, and good fittability to skin; antiperspirants
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010WO2010141805A1 Heterocyclic amides as modulators of trpa1
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010140636A1 Asymmetric hydrogenation catalyst
12/09/2010WO2010096677A3 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
12/09/2010US20100311986 Preparing method of methoxypolyethyleneglycol ethylmaleimide
12/09/2010US20100311794 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/09/2010US20100311750 Organic compounds
12/09/2010US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor
12/09/2010US20100311593 Haloalkylmethyleneoxyphenyl-substituted ketoenols
12/09/2010US20100311207 Compounds Having A Diphenyl Oxide Backbone and Maleimide Functional Group
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100308285 Novel colorant compound and blue resist composition for use in color filter containing the same
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258706A2 Functionalized ionic liquids, and methods of use thereof
12/08/2010EP2258689A1 Benzylated PDE4 inhibitors
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP2258681A2 Aromatic Derivatives as HIV Aspartyl Protease Inhibitors
12/08/2010EP2258680A2 Aromatic derivatives as HIV aspartyl protease inhibitors
12/08/2010EP2258477A1 Catalyst and reaction process
12/08/2010EP2257548A1 Therapeutic compounds
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP1771432B1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
12/08/2010CN1929840B 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation
12/08/2010CN101910126A Proline analogs as ligands for cannabinoid receptors for the treatment of pain
12/08/2010CN101910125A Compounds from mycelium of antrodia cinnamomea and use thereof
12/08/2010CN101910124A Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine
12/08/2010CN101910123A Process for the preparation of 6-substituted-1-(2H)-isoquinolinones
12/08/2010CN101906186A Method for preparing fatty acid molecular imprinted polymer
12/08/2010CN101906060A Preparation method of N-substituted 3-aminomethyl pyrrolidine
12/08/2010CN101906056A Cycloalkane amine compound as M2 inhibitor and application thereof
12/08/2010CN101906053A 酰胺衍生物 Amide derivatives
12/08/2010CN101391975B Process for separation and purification of N-vinyl pyrrolidone
12/08/2010CN101376641B Carbapenem penicillin ertapenem intermediate, and preparation and use thereof
12/08/2010CN101146777B Carboxanilides as microbiocides
12/08/2010CN101128446B Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
12/07/2010US7846963 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring
12/07/2010US7846875 for immobilization of nucleic acids; phosphoramidite derivatives; solid phase synthesis
12/07/2010US7846576 Onium salt, electrolyte for non-aqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using elecrolyte containing onium salt
12/02/2010WO2010094029A3 Asymmetric cyclopropanation with succinimidyl diazoacetate
12/02/2010WO2010079413A3 Dipeptidyl peptidase iv inhibitors
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305056 Cysteine protease inhibitors for the treatment of parasitic disease
12/01/2010EP2256838A1 Organic light emitting devices having charge carrier blocking layers comprising metalcomplexes
12/01/2010EP2255829A2 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
12/01/2010EP2254863A1 Pesticidal condensed - ring aryl compounds
12/01/2010EP2146951B1 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
12/01/2010CN101903344A Process for preparing of N-methyl pyrrolidone
12/01/2010CN101903343A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
12/01/2010CN101903341A Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof
12/01/2010CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101899003A Quinoline derivative-N-oxide ligand as well as preparation method and application thereof
12/01/2010CN101898993A Preparation method of 4-hydroxyl ketopyrrolidine-2-acetamide
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 404